Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Findings raise concern over bTB tests
Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France.

Mycobacterium Microti infection confirmed in a cow in France

Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France, raising concern over the reliability of diagnostic tests used for bovine TB (bTB) surveillance.

Reporting in Veterinary Record (Vol 180 No 17), researchers say the discovery follows an investigation of M Microti infection in a dairy goat in the same region.

Communicating the finding in 2015, the team demonstrated that the bacteria could be responsible for misleading diagnostic results for bTB.

In this latest study, researchers found that the suspected cattle herd had shared the same pasture with two bTB confirmed herds. As such, they submitted the herd for testing and culled one animal ‘with a doubtful result’ for direct diagnosis.

An analysis revealed the cow harboured the same genotype of M microti that was identified in the goat, as well as a badger that was living in the same area.

M Microti is a member of the Mycobacterium tuberculosis complex (MTBC), which also includes major human and animal pathogens like M tuberculosis and Mycobacterium bovis. It was first described as the cause of tuberculosis in small wild mammals, but it can also infect other species - including humans.

Previously in the UK, M microti has been isolated in skin test reactor cattle, demonstrating the risk of infection in livestock and of interference with bTB diagnosis.
The researchers believe that all these findings raise concerns about the reliability of diagnostic tests used for bTb surveillance.

‘The use of highly specific tests based on specific antigens such as ESAT6 and CFP10 (which are absent in M microti and already currently used in the interferon gamma test employed in France) are highly recommended to accurately identify M Bovis infection at antemortem examination,’ they write.

'At postmortem diagnosis, the use of specific molecular tools should be considered to rapidly distinguish pathogens within the MTBC and to avoid misleading diagnosis’.

The research was led by scientists from ANSES - the French agency for Food, Environmental and Occupational Health & Safety. 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.